Abstract
Rett Syndrome (RTT) is a severe dominant X-linked neurological disorder affecting 1:10,000 females. In -95% of the cases, RTT is caused by deleterious mutations in the Methyl-CpG-binding protein 2 (MeCP2). Development and assessment of RTT treatments have been increased since the finding that the rescue of MeCP2 function can restore RTT phenotype in mouse models. Here, I present the transcriptional analysis at single-nucleus resolution coupled with tissue-level DNA methylation profiles of a phenotypically rescued RTT mouse model. Results suggest that neurodevelopmental damage may not be restored in symptomatic and aged individuals, in which supplementary treatments might need to be considered.
Original language | English |
---|---|
Qualification | Doctor of Philosophy |
Awarding Institution |
|
Supervisors/Advisors |
|
Thesis sponsors | |
Award date | 12 Apr 2021 |
DOIs | |
Publication status | Unpublished - 2021 |